Quarterly Results Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Mar'23
Net Sales
17.70
17.05
15.60
17.43
16.61
17.66
15.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17.70
17.05
15.60
17.43
16.61
17.66
15.26
Raw Material Cost
2.44
2.27
2.84
2.42
2.62
1.98
3.17
Purchase of Finished goods
5.41
3.94
5.59
6.41
5.80
3.28
4.24
(Increase) / Decrease In Stocks
0.32
3.08
-2.24
-0.20
-0.11
4.19
-1.19
Employee Cost
2.61
2.33
2.47
2.53
2.55
2.52
3.07
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
0.01
0.00
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
6.03
5.01
6.32
5.76
4.93
5.33
5.50
Total Expenditure (Excl Depreciation)
16.80
16.64
14.99
16.92
15.78
17.30
14.79
Operating Profit (PBDIT) excl Other Income
0.90
0.41
0.61
0.51
0.83
0.36
0.47
Other Income
0.03
0.04
0.31
0.03
0.09
0.00
0.04
Operating Profit (PBDIT)
0.93
0.45
0.92
0.54
0.92
0.36
0.51
Interest
0.03
0.02
0.01
0.02
0.01
0.02
0.02
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
0.90
0.43
0.91
0.52
0.91
0.34
0.49
Depreciation
0.17
0.16
0.19
0.14
0.13
0.12
0.13
Profit Before Tax
0.74
0.27
0.72
0.38
0.76
0.21
0.38
Tax
0.24
0.10
0.12
0.17
0.21
0.10
0.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
0.50
0.17
0.59
0.21
0.55
0.11
0.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
0.50
0.17
0.59
0.21
0.55
0.11
0.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
0.50
0.17
0.59
0.21
0.55
0.11
0.27
Equity Capital
9.66
9.66
9.66
9.66
9.66
9.66
9.66
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
0.52
0.18
0.61
0.22
0.57
0.11
0.28
Diluted Earnings per share
1.95
0.17
0.62
0.21
0.57
0.11
0.26
Operating Profit Margin (Excl OI)
5.08%
2.4%
3.91%
2.93%
5.0%
2.04%
3.08%
Gross Profit Margin
5.08%
2.52%
5.83%
2.98%
5.48%
1.93%
3.21%
PAT Margin
2.82%
1.0%
3.78%
1.2%
3.31%
0.62%
1.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2024 is 3.79% vs 3.81% in Sep 2024
Standalone Net Profit
QoQ Growth in quarter ended Dec 2024 is 12.00% vs 194.12% in Sep 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2024 is 8.79% vs 121.95% in Sep 2024
Interest
QoQ Growth in quarter ended Dec 2024 is 0.00% vs 50.00% in Sep 2024
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024
Compare Quarterly Results Of Sandu Pharma. With
Figures in Rs cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
17.70
471.50
-453.80
-96.25%
Other Operating Income
0.00
0.00
0.00
Total Operating income
17.70
471.50
-453.80
-96.25%
Raw Material Cost
2.44
174.70
-172.26
-98.60%
Purchase of Finished goods
5.41
201.31
-195.90
-97.31%
(Increase) / Decrease In Stocks
0.32
29.60
-29.28
-98.92%
Employee Cost
2.61
15.66
-13.05
-83.33%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
-0.02
-200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
6.03
16.39
-10.36
-63.21%
Total Expenditure (Excl Depreciation)
16.80
437.67
-420.87
-96.16%
Operating Profit (PBDIT) excl Other Income
0.90
33.83
-32.93
-97.34%
Other Income
0.03
-0.19
0.22
115.79%
Operating Profit (PBDIT)
0.93
33.64
-32.71
-97.24%
Interest
0.03
8.27
-8.24
-99.64%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
0.90
25.37
-24.47
-96.45%
Depreciation
0.17
5.76
-5.59
-97.05%
Profit Before Tax
0.74
20.62
-19.88
-96.41%
Tax
0.24
5.62
-5.38
-95.73%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
0.50
13.99
-13.49
-96.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
0.50
13.99
-13.49
-96.43%
Share in Profit of Associates
0.00
1.01
-1.01
-100.00%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
0.50
15.00
-14.50
-96.67%
Equity Capital
9.66
85.86
-76.20
-88.75%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.52
1.75
-1.23
-70.29%
Diluted Earnings per share
1.95
1.75
0.20
11.43%
Operating Profit Margin (Excl OI)
5.08%
7.17%
0.00
-2.09%
Gross Profit Margin
5.08%
5.38%
0.00
-0.30%
PAT Margin
2.82%
3.18%
0.00
-0.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 18.37 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is 3.79% vs 3.81% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 5.39% vs 1.99% in Dec 2023
Quarterly - Standalone Net Profit
Standalone Net Profit 0.56 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is 12.00% vs 194.12% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 166.67% vs -56.25% in Dec 2023
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.99 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is 8.79% vs 121.95% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 94.12% vs -37.80% in Dec 2023
Quarterly - Interest
Interest 0.03 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is 0.00% vs 50.00% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 50.00% vs 0.00% in Dec 2023
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.39%
in Dec 2024Figures in Rs %
QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024
YoY Growth in quarter ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
